Cetera Advisors LLC Emergent Bio Solutions Inc. Transaction History

Cetera Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.5 - $3.41 $253,975 - $577,370	169,317 New	169,317 $428,000
Q3 2023 Nov 14, 2023	BUY	$3.17 - $7.91 $202,163 - $504,452	63,774 Added 103.97%	125,112 $425,000
Q2 2023 Aug 09, 2023	BUY	$7.35 - $13.21 $370,858 - $666,536	50,457 Added 463.72%	61,338 $450,000
Q1 2023 May 15, 2023	BUY	$7.79 - $16.29 $84,762 - $177,251	10,881 New	10,881 $112,000
Q4 2020 Feb 17, 2021	SELL	$79.17 - $111.47 $663,365 - $934,007	-8,379 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$81.91 - $134.94 $8,682 - $14,303	106 Added 1.28%	8,379 $866,000
Q2 2020 Aug 13, 2020	BUY	$54.33 - $89.52 $186,677 - $307,590	3,436 Added 71.04%	8,273 $654,000
Q1 2020 May 08, 2020	BUY	$49.34 - $68.76 $238,657 - $332,592	4,837 New	4,837 $280,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.